Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)

NCT05033145 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

312

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: AZVUDINE
DRUG: AZVUDINE placebo

Sponsor

HRH Pharmaceuticals Limited

Collaborators

[object Object]
[object Object]